On June 18, 2026, Tsoi Hoi Shan, Chairman of the Board of TUL, was invited to attend the Novo Nordisk roundtable to discuss the global impact of Chinese innovation. During the meeting, senior executives of TUL and Maziar Mike Doustdar, President and CEO of Novo Nordisk, engaged in discussions on the influence and future direction of Chinese innovation on the global stage, fully exchanged views on industry trends and global cooperation, and also discussed their cooperation strategies, further exchanging details and future directions.